Showing all 9 results
Daclatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dihydrochloride Salt Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the active virological agent.
Active Ingredient Strength Primary Clinical Function Daclatasvir Dihydrochloride USP/Ph.Eur. 60 mg The Standard Eradication Macrodose: The definitive, globally standardized daily therapeutic payload utilized for the vast majority of patients to achieve a Sustained Virologic Response (SVR12 – Clinical Cure). Daclatasvir Dihydrochloride USP/Ph.Eur. 30 mg The CYP3A4 Titration Unit: The strict, mandatory dose-reduction unit utilized for patients who are co-infected with HIV and taking strong CYP3A inhibitors (like Ritonavir or Atazanavir). Excipients Anhydrous Lactose / Microcrystalline Cellulose / Croscarmellose Sodium / Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film (Opadry Green) Diluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing advanced dissolution-enhancing matrices to ensure the Dihydrochloride salt separates perfectly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Heavy-Gauge HDPE Bottles of 28 (Optimized exactly for a 4-week supply in strict 12-week or 24-week curative regimens).
Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.
Active Ingredient Strength Primary Clinical Function Dolutegravir (as Sodium) USP/Ph.Eur. 50 mg The Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load. Excipients D-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression. Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg The Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Efavirenz Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.
Active Ingredient Strength Primary Clinical Function Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg
(Eq. to 245 mg Tenofovir Disoproxil)The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry) Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Ganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Ganciclovir USP/Ph.Eur. 250 mg Renal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance). Ganciclovir USP/Ph.Eur. 500 mg Global Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).
Ledipasvir & sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
